Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

16. Mai 2022 08:30 ET | Quelle: Vyant Bio, Inc.

Vyant Bio Reports First Quarter 2022 Results and Provides Strategic and Business Highlights

Conference Call and Webcast Today at 4:30 pm ET Scientific and Business Highlights ●Progress in the discovery of small molecule therapeutics to treat neurodevelopmental and...
30. März 2022 07:50 ET | Quelle: Vyant Bio, Inc.

Vyant Bio Reports Fourth Quarter and Year-End 2021 Results and Provides Strategic and Business Highlights

Highlights Focused as a pure-play drug discovery and development biotechnology companyPrimary work on the discovery of small molecule therapeutics to treat neurodevelopmental and neurodegenerative...
19. August 2021 09:27 ET | Quelle: Vyant Bio, Inc.

Vyant Bio and Cyclica Announce a Strategic Collaboration to Identify Compounds to Treat CDKL5 Deficiency Disorder

CDKL5 Deficiency Disorder (“CDD”) is a severe neurodevelopmental epileptic encephalopathy disorder with no effective treatments or cureCollaboration creates opportunities to identify, validate, and...